nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—ABCB1—Dactinomycin—muscle cancer	0.207	0.258	CbGbCtD
Ticagrelor—ABCB1—Vincristine—muscle cancer	0.128	0.159	CbGbCtD
Ticagrelor—ABCB1—Etoposide—muscle cancer	0.117	0.146	CbGbCtD
Ticagrelor—ABCB1—Doxorubicin—muscle cancer	0.0798	0.0993	CbGbCtD
Ticagrelor—ABCB1—Methotrexate—muscle cancer	0.0773	0.0962	CbGbCtD
Ticagrelor—CYP3A4—Vincristine—muscle cancer	0.0765	0.0952	CbGbCtD
Ticagrelor—CYP3A4—Etoposide—muscle cancer	0.0701	0.0873	CbGbCtD
Ticagrelor—CYP3A4—Doxorubicin—muscle cancer	0.0478	0.0595	CbGbCtD
Ticagrelor—Cardiac tamponade—Methotrexate—muscle cancer	0.00999	0.0509	CcSEcCtD
Ticagrelor—Gastrointestinal ulcer haemorrhage—Methotrexate—muscle cancer	0.00705	0.0359	CcSEcCtD
Ticagrelor—Cerebral haemorrhage—Vincristine—muscle cancer	0.00503	0.0256	CcSEcCtD
Ticagrelor—Injection site haemorrhage—Doxorubicin—muscle cancer	0.00435	0.0222	CcSEcCtD
Ticagrelor—Nephropathy toxic—Etoposide—muscle cancer	0.00393	0.02	CcSEcCtD
Ticagrelor—Dyspnoea exertional—Doxorubicin—muscle cancer	0.00388	0.0198	CcSEcCtD
Ticagrelor—Hyperuricaemia—Vincristine—muscle cancer	0.003	0.0153	CcSEcCtD
Ticagrelor—Blood uric acid increased—Vincristine—muscle cancer	0.00284	0.0145	CcSEcCtD
Ticagrelor—Hyperuricaemia—Etoposide—muscle cancer	0.00243	0.0124	CcSEcCtD
Ticagrelor—Blood uric acid increased—Etoposide—muscle cancer	0.0023	0.0117	CcSEcCtD
Ticagrelor—Gingival bleeding—Doxorubicin—muscle cancer	0.00206	0.0105	CcSEcCtD
Ticagrelor—Haematemesis—Methotrexate—muscle cancer	0.00195	0.00992	CcSEcCtD
Ticagrelor—Lung disorder—Methotrexate—muscle cancer	0.00191	0.00973	CcSEcCtD
Ticagrelor—Serum creatinine increased—Doxorubicin—muscle cancer	0.0019	0.0097	CcSEcCtD
Ticagrelor—Cardiac failure congestive—Etoposide—muscle cancer	0.00181	0.00921	CcSEcCtD
Ticagrelor—Haematemesis—Doxorubicin—muscle cancer	0.00169	0.00859	CcSEcCtD
Ticagrelor—Cardiac failure—Etoposide—muscle cancer	0.00168	0.00856	CcSEcCtD
Ticagrelor—Lung disorder—Doxorubicin—muscle cancer	0.00165	0.00843	CcSEcCtD
Ticagrelor—Petechiae—Methotrexate—muscle cancer	0.00164	0.00838	CcSEcCtD
Ticagrelor—Haemoptysis—Doxorubicin—muscle cancer	0.00158	0.00806	CcSEcCtD
Ticagrelor—Vaginal haemorrhage—Doxorubicin—muscle cancer	0.00158	0.00806	CcSEcCtD
Ticagrelor—Bone disorder—Methotrexate—muscle cancer	0.0015	0.00763	CcSEcCtD
Ticagrelor—Oliguria—Methotrexate—muscle cancer	0.00147	0.00748	CcSEcCtD
Ticagrelor—Hyperuricaemia—Methotrexate—muscle cancer	0.00146	0.00743	CcSEcCtD
Ticagrelor—Petechiae—Doxorubicin—muscle cancer	0.00142	0.00725	CcSEcCtD
Ticagrelor—Urinary tract disorder—Vincristine—muscle cancer	0.00138	0.00704	CcSEcCtD
Ticagrelor—Blood uric acid increased—Methotrexate—muscle cancer	0.00138	0.00702	CcSEcCtD
Ticagrelor—Connective tissue disorder—Vincristine—muscle cancer	0.00138	0.00701	CcSEcCtD
Ticagrelor—Urethral disorder—Vincristine—muscle cancer	0.00137	0.00699	CcSEcCtD
Ticagrelor—Neoplasm malignant—Doxorubicin—muscle cancer	0.00137	0.00699	CcSEcCtD
Ticagrelor—Melaena—Methotrexate—muscle cancer	0.00132	0.00673	CcSEcCtD
Ticagrelor—Cardiac disorder—Vincristine—muscle cancer	0.0013	0.00662	CcSEcCtD
Ticagrelor—Bone disorder—Doxorubicin—muscle cancer	0.0013	0.00661	CcSEcCtD
Ticagrelor—Rectal haemorrhage—Doxorubicin—muscle cancer	0.0013	0.00661	CcSEcCtD
Ticagrelor—Oliguria—Doxorubicin—muscle cancer	0.00127	0.00647	CcSEcCtD
Ticagrelor—Angiopathy—Vincristine—muscle cancer	0.00127	0.00647	CcSEcCtD
Ticagrelor—Hyperuricaemia—Doxorubicin—muscle cancer	0.00126	0.00643	CcSEcCtD
Ticagrelor—Mediastinal disorder—Vincristine—muscle cancer	0.00126	0.00643	CcSEcCtD
Ticagrelor—Mental disorder—Vincristine—muscle cancer	0.00123	0.00625	CcSEcCtD
Ticagrelor—Ecchymosis—Methotrexate—muscle cancer	0.00122	0.00623	CcSEcCtD
Ticagrelor—Gynaecomastia—Methotrexate—muscle cancer	0.00121	0.00616	CcSEcCtD
Ticagrelor—Blood uric acid increased—Doxorubicin—muscle cancer	0.00119	0.00608	CcSEcCtD
Ticagrelor—Back pain—Vincristine—muscle cancer	0.00118	0.006	CcSEcCtD
Ticagrelor—Melaena—Doxorubicin—muscle cancer	0.00114	0.00583	CcSEcCtD
Ticagrelor—Urinary tract disorder—Etoposide—muscle cancer	0.00112	0.0057	CcSEcCtD
Ticagrelor—Urethral disorder—Etoposide—muscle cancer	0.00111	0.00566	CcSEcCtD
Ticagrelor—Vertigo—Vincristine—muscle cancer	0.00109	0.00558	CcSEcCtD
Ticagrelor—Renal failure acute—Methotrexate—muscle cancer	0.00106	0.00542	CcSEcCtD
Ticagrelor—Eye disorder—Etoposide—muscle cancer	0.00106	0.0054	CcSEcCtD
Ticagrelor—Ecchymosis—Doxorubicin—muscle cancer	0.00106	0.00539	CcSEcCtD
Ticagrelor—Cardiac disorder—Etoposide—muscle cancer	0.00105	0.00536	CcSEcCtD
Ticagrelor—Hypertension—Vincristine—muscle cancer	0.00105	0.00536	CcSEcCtD
Ticagrelor—Angiopathy—Etoposide—muscle cancer	0.00103	0.00524	CcSEcCtD
Ticagrelor—Immune system disorder—Etoposide—muscle cancer	0.00102	0.00522	CcSEcCtD
Ticagrelor—Mediastinal disorder—Etoposide—muscle cancer	0.00102	0.00521	CcSEcCtD
Ticagrelor—Nervous system disorder—Vincristine—muscle cancer	0.000975	0.00497	CcSEcCtD
Ticagrelor—Fatigue—Dactinomycin—muscle cancer	0.00096	0.00489	CcSEcCtD
Ticagrelor—Back pain—Etoposide—muscle cancer	0.000955	0.00486	CcSEcCtD
Ticagrelor—Cardiac failure congestive—Doxorubicin—muscle cancer	0.000937	0.00478	CcSEcCtD
Ticagrelor—Hypotension—Vincristine—muscle cancer	0.000929	0.00473	CcSEcCtD
Ticagrelor—Renal failure acute—Doxorubicin—muscle cancer	0.000921	0.00469	CcSEcCtD
Ticagrelor—Feeling abnormal—Dactinomycin—muscle cancer	0.000917	0.00467	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00091	0.00464	CcSEcCtD
Ticagrelor—Paraesthesia—Vincristine—muscle cancer	0.000893	0.00455	CcSEcCtD
Ticagrelor—Breast disorder—Methotrexate—muscle cancer	0.000887	0.00452	CcSEcCtD
Ticagrelor—Vertigo—Etoposide—muscle cancer	0.000887	0.00452	CcSEcCtD
Ticagrelor—Abdominal pain—Dactinomycin—muscle cancer	0.00088	0.00448	CcSEcCtD
Ticagrelor—Body temperature increased—Dactinomycin—muscle cancer	0.00088	0.00448	CcSEcCtD
Ticagrelor—Cardiac failure—Doxorubicin—muscle cancer	0.000871	0.00444	CcSEcCtD
Ticagrelor—Loss of consciousness—Etoposide—muscle cancer	0.000868	0.00442	CcSEcCtD
Ticagrelor—Cough—Etoposide—muscle cancer	0.000861	0.00439	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Vincristine—muscle cancer	0.000859	0.00437	CcSEcCtD
Ticagrelor—Fatigue—Vincristine—muscle cancer	0.000857	0.00437	CcSEcCtD
Ticagrelor—Hypertension—Etoposide—muscle cancer	0.000852	0.00434	CcSEcCtD
Ticagrelor—Constipation—Vincristine—muscle cancer	0.00085	0.00433	CcSEcCtD
Ticagrelor—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.00085	0.00433	CcSEcCtD
Ticagrelor—Chest pain—Etoposide—muscle cancer	0.00084	0.00428	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000835	0.00425	CcSEcCtD
Ticagrelor—Hypersensitivity—Dactinomycin—muscle cancer	0.00082	0.00418	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Vincristine—muscle cancer	0.000813	0.00414	CcSEcCtD
Ticagrelor—Confusional state—Etoposide—muscle cancer	0.000812	0.00414	CcSEcCtD
Ticagrelor—Asthenia—Dactinomycin—muscle cancer	0.000799	0.00407	CcSEcCtD
Ticagrelor—Blood creatinine increased—Doxorubicin—muscle cancer	0.000796	0.00406	CcSEcCtD
Ticagrelor—Body temperature increased—Vincristine—muscle cancer	0.000786	0.004	CcSEcCtD
Ticagrelor—Abdominal pain—Vincristine—muscle cancer	0.000786	0.004	CcSEcCtD
Ticagrelor—Skin disorder—Etoposide—muscle cancer	0.000782	0.00399	CcSEcCtD
Ticagrelor—Breast disorder—Doxorubicin—muscle cancer	0.000768	0.00391	CcSEcCtD
Ticagrelor—Diarrhoea—Dactinomycin—muscle cancer	0.000762	0.00388	CcSEcCtD
Ticagrelor—Hypotension—Etoposide—muscle cancer	0.000753	0.00383	CcSEcCtD
Ticagrelor—Gastritis—Doxorubicin—muscle cancer	0.000752	0.00383	CcSEcCtD
Ticagrelor—Hypersensitivity—Vincristine—muscle cancer	0.000733	0.00373	CcSEcCtD
Ticagrelor—Paraesthesia—Etoposide—muscle cancer	0.000723	0.00369	CcSEcCtD
Ticagrelor—Haematuria—Methotrexate—muscle cancer	0.000721	0.00368	CcSEcCtD
Ticagrelor—Dyspnoea—Etoposide—muscle cancer	0.000718	0.00366	CcSEcCtD
Ticagrelor—Epistaxis—Methotrexate—muscle cancer	0.000714	0.00364	CcSEcCtD
Ticagrelor—Asthenia—Vincristine—muscle cancer	0.000713	0.00363	CcSEcCtD
Ticagrelor—Vomiting—Dactinomycin—muscle cancer	0.000708	0.00361	CcSEcCtD
Ticagrelor—Rash—Dactinomycin—muscle cancer	0.000702	0.00358	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Etoposide—muscle cancer	0.000695	0.00354	CcSEcCtD
Ticagrelor—Fatigue—Etoposide—muscle cancer	0.000695	0.00354	CcSEcCtD
Ticagrelor—Constipation—Etoposide—muscle cancer	0.000689	0.00351	CcSEcCtD
Ticagrelor—Haemoglobin—Methotrexate—muscle cancer	0.000683	0.00348	CcSEcCtD
Ticagrelor—Diarrhoea—Vincristine—muscle cancer	0.00068	0.00347	CcSEcCtD
Ticagrelor—Haemorrhage—Methotrexate—muscle cancer	0.000679	0.00346	CcSEcCtD
Ticagrelor—Urinary tract disorder—Methotrexate—muscle cancer	0.000671	0.00342	CcSEcCtD
Ticagrelor—Urethral disorder—Methotrexate—muscle cancer	0.000666	0.00339	CcSEcCtD
Ticagrelor—Feeling abnormal—Etoposide—muscle cancer	0.000664	0.00338	CcSEcCtD
Ticagrelor—Nausea—Dactinomycin—muscle cancer	0.000661	0.00337	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Etoposide—muscle cancer	0.000659	0.00336	CcSEcCtD
Ticagrelor—Dizziness—Vincristine—muscle cancer	0.000658	0.00335	CcSEcCtD
Ticagrelor—Abdominal pain—Etoposide—muscle cancer	0.000637	0.00324	CcSEcCtD
Ticagrelor—Body temperature increased—Etoposide—muscle cancer	0.000637	0.00324	CcSEcCtD
Ticagrelor—Eye disorder—Methotrexate—muscle cancer	0.000635	0.00323	CcSEcCtD
Ticagrelor—Vomiting—Vincristine—muscle cancer	0.000632	0.00322	CcSEcCtD
Ticagrelor—Cardiac disorder—Methotrexate—muscle cancer	0.00063	0.00321	CcSEcCtD
Ticagrelor—Rash—Vincristine—muscle cancer	0.000627	0.00319	CcSEcCtD
Ticagrelor—Dermatitis—Vincristine—muscle cancer	0.000626	0.00319	CcSEcCtD
Ticagrelor—Haematuria—Doxorubicin—muscle cancer	0.000625	0.00318	CcSEcCtD
Ticagrelor—Headache—Vincristine—muscle cancer	0.000623	0.00317	CcSEcCtD
Ticagrelor—Epistaxis—Doxorubicin—muscle cancer	0.000618	0.00315	CcSEcCtD
Ticagrelor—Angiopathy—Methotrexate—muscle cancer	0.000616	0.00314	CcSEcCtD
Ticagrelor—Immune system disorder—Methotrexate—muscle cancer	0.000613	0.00313	CcSEcCtD
Ticagrelor—Mediastinal disorder—Methotrexate—muscle cancer	0.000612	0.00312	CcSEcCtD
Ticagrelor—Bradycardia—Doxorubicin—muscle cancer	0.000599	0.00305	CcSEcCtD
Ticagrelor—Mental disorder—Methotrexate—muscle cancer	0.000595	0.00303	CcSEcCtD
Ticagrelor—Hypersensitivity—Etoposide—muscle cancer	0.000594	0.00302	CcSEcCtD
Ticagrelor—Malnutrition—Methotrexate—muscle cancer	0.000591	0.00301	CcSEcCtD
Ticagrelor—Haemoglobin—Doxorubicin—muscle cancer	0.000591	0.00301	CcSEcCtD
Ticagrelor—Nausea—Vincristine—muscle cancer	0.000591	0.00301	CcSEcCtD
Ticagrelor—Haemorrhage—Doxorubicin—muscle cancer	0.000588	0.003	CcSEcCtD
Ticagrelor—Urinary tract disorder—Doxorubicin—muscle cancer	0.000581	0.00296	CcSEcCtD
Ticagrelor—Oedema peripheral—Doxorubicin—muscle cancer	0.000579	0.00295	CcSEcCtD
Ticagrelor—Asthenia—Etoposide—muscle cancer	0.000578	0.00294	CcSEcCtD
Ticagrelor—Connective tissue disorder—Doxorubicin—muscle cancer	0.000578	0.00294	CcSEcCtD
Ticagrelor—Urethral disorder—Doxorubicin—muscle cancer	0.000576	0.00294	CcSEcCtD
Ticagrelor—Back pain—Methotrexate—muscle cancer	0.000572	0.00291	CcSEcCtD
Ticagrelor—Pruritus—Etoposide—muscle cancer	0.00057	0.0029	CcSEcCtD
Ticagrelor—Diarrhoea—Etoposide—muscle cancer	0.000551	0.00281	CcSEcCtD
Ticagrelor—Eye disorder—Doxorubicin—muscle cancer	0.00055	0.0028	CcSEcCtD
Ticagrelor—Cardiac disorder—Doxorubicin—muscle cancer	0.000546	0.00278	CcSEcCtD
Ticagrelor—Angiopathy—Doxorubicin—muscle cancer	0.000534	0.00272	CcSEcCtD
Ticagrelor—Dizziness—Etoposide—muscle cancer	0.000533	0.00271	CcSEcCtD
Ticagrelor—Immune system disorder—Doxorubicin—muscle cancer	0.000531	0.00271	CcSEcCtD
Ticagrelor—Vertigo—Methotrexate—muscle cancer	0.000531	0.00271	CcSEcCtD
Ticagrelor—Mediastinal disorder—Doxorubicin—muscle cancer	0.00053	0.0027	CcSEcCtD
Ticagrelor—Cough—Methotrexate—muscle cancer	0.000516	0.00263	CcSEcCtD
Ticagrelor—Mental disorder—Doxorubicin—muscle cancer	0.000515	0.00262	CcSEcCtD
Ticagrelor—Vomiting—Etoposide—muscle cancer	0.000512	0.00261	CcSEcCtD
Ticagrelor—Malnutrition—Doxorubicin—muscle cancer	0.000512	0.00261	CcSEcCtD
Ticagrelor—Rash—Etoposide—muscle cancer	0.000508	0.00259	CcSEcCtD
Ticagrelor—Dermatitis—Etoposide—muscle cancer	0.000507	0.00259	CcSEcCtD
Ticagrelor—Headache—Etoposide—muscle cancer	0.000505	0.00257	CcSEcCtD
Ticagrelor—Chest pain—Methotrexate—muscle cancer	0.000503	0.00256	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.0005	0.00255	CcSEcCtD
Ticagrelor—Back pain—Doxorubicin—muscle cancer	0.000495	0.00252	CcSEcCtD
Ticagrelor—Confusional state—Methotrexate—muscle cancer	0.000487	0.00248	CcSEcCtD
Ticagrelor—Nausea—Etoposide—muscle cancer	0.000478	0.00244	CcSEcCtD
Ticagrelor—Nervous system disorder—Methotrexate—muscle cancer	0.000473	0.00241	CcSEcCtD
Ticagrelor—Skin disorder—Methotrexate—muscle cancer	0.000469	0.00239	CcSEcCtD
Ticagrelor—Vertigo—Doxorubicin—muscle cancer	0.00046	0.00234	CcSEcCtD
Ticagrelor—Syncope—Doxorubicin—muscle cancer	0.000459	0.00234	CcSEcCtD
Ticagrelor—Hypotension—Methotrexate—muscle cancer	0.000451	0.0023	CcSEcCtD
Ticagrelor—Loss of consciousness—Doxorubicin—muscle cancer	0.00045	0.00229	CcSEcCtD
Ticagrelor—Cough—Doxorubicin—muscle cancer	0.000447	0.00228	CcSEcCtD
Ticagrelor—Hypertension—Doxorubicin—muscle cancer	0.000442	0.00225	CcSEcCtD
Ticagrelor—Chest pain—Doxorubicin—muscle cancer	0.000436	0.00222	CcSEcCtD
Ticagrelor—Paraesthesia—Methotrexate—muscle cancer	0.000433	0.00221	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000433	0.00221	CcSEcCtD
Ticagrelor—Dyspnoea—Methotrexate—muscle cancer	0.00043	0.00219	CcSEcCtD
Ticagrelor—Dyspepsia—Methotrexate—muscle cancer	0.000425	0.00216	CcSEcCtD
Ticagrelor—Confusional state—Doxorubicin—muscle cancer	0.000421	0.00215	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000417	0.00212	CcSEcCtD
Ticagrelor—Fatigue—Methotrexate—muscle cancer	0.000416	0.00212	CcSEcCtD
Ticagrelor—Shock—Doxorubicin—muscle cancer	0.000411	0.00209	CcSEcCtD
Ticagrelor—Nervous system disorder—Doxorubicin—muscle cancer	0.00041	0.00209	CcSEcCtD
Ticagrelor—Skin disorder—Doxorubicin—muscle cancer	0.000406	0.00207	CcSEcCtD
Ticagrelor—Feeling abnormal—Methotrexate—muscle cancer	0.000398	0.00203	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Methotrexate—muscle cancer	0.000395	0.00201	CcSEcCtD
Ticagrelor—Hypotension—Doxorubicin—muscle cancer	0.00039	0.00199	CcSEcCtD
Ticagrelor—Body temperature increased—Methotrexate—muscle cancer	0.000381	0.00194	CcSEcCtD
Ticagrelor—Abdominal pain—Methotrexate—muscle cancer	0.000381	0.00194	CcSEcCtD
Ticagrelor—Paraesthesia—Doxorubicin—muscle cancer	0.000375	0.00191	CcSEcCtD
Ticagrelor—Dyspnoea—Doxorubicin—muscle cancer	0.000372	0.0019	CcSEcCtD
Ticagrelor—Dyspepsia—Doxorubicin—muscle cancer	0.000368	0.00187	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000361	0.00184	CcSEcCtD
Ticagrelor—Fatigue—Doxorubicin—muscle cancer	0.00036	0.00184	CcSEcCtD
Ticagrelor—Constipation—Doxorubicin—muscle cancer	0.000357	0.00182	CcSEcCtD
Ticagrelor—Hypersensitivity—Methotrexate—muscle cancer	0.000356	0.00181	CcSEcCtD
Ticagrelor—Asthenia—Methotrexate—muscle cancer	0.000346	0.00176	CcSEcCtD
Ticagrelor—Feeling abnormal—Doxorubicin—muscle cancer	0.000344	0.00175	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000342	0.00174	CcSEcCtD
Ticagrelor—Pruritus—Methotrexate—muscle cancer	0.000341	0.00174	CcSEcCtD
Ticagrelor—Abdominal pain—Doxorubicin—muscle cancer	0.00033	0.00168	CcSEcCtD
Ticagrelor—Body temperature increased—Doxorubicin—muscle cancer	0.00033	0.00168	CcSEcCtD
Ticagrelor—Diarrhoea—Methotrexate—muscle cancer	0.00033	0.00168	CcSEcCtD
Ticagrelor—Dizziness—Methotrexate—muscle cancer	0.000319	0.00163	CcSEcCtD
Ticagrelor—Hypersensitivity—Doxorubicin—muscle cancer	0.000308	0.00157	CcSEcCtD
Ticagrelor—Vomiting—Methotrexate—muscle cancer	0.000307	0.00156	CcSEcCtD
Ticagrelor—Rash—Methotrexate—muscle cancer	0.000304	0.00155	CcSEcCtD
Ticagrelor—Dermatitis—Methotrexate—muscle cancer	0.000304	0.00155	CcSEcCtD
Ticagrelor—Headache—Methotrexate—muscle cancer	0.000302	0.00154	CcSEcCtD
Ticagrelor—Asthenia—Doxorubicin—muscle cancer	0.0003	0.00153	CcSEcCtD
Ticagrelor—Pruritus—Doxorubicin—muscle cancer	0.000296	0.00151	CcSEcCtD
Ticagrelor—Nausea—Methotrexate—muscle cancer	0.000287	0.00146	CcSEcCtD
Ticagrelor—Diarrhoea—Doxorubicin—muscle cancer	0.000286	0.00146	CcSEcCtD
Ticagrelor—Dizziness—Doxorubicin—muscle cancer	0.000276	0.00141	CcSEcCtD
Ticagrelor—Vomiting—Doxorubicin—muscle cancer	0.000266	0.00135	CcSEcCtD
Ticagrelor—Rash—Doxorubicin—muscle cancer	0.000263	0.00134	CcSEcCtD
Ticagrelor—Dermatitis—Doxorubicin—muscle cancer	0.000263	0.00134	CcSEcCtD
Ticagrelor—Headache—Doxorubicin—muscle cancer	0.000262	0.00133	CcSEcCtD
Ticagrelor—Nausea—Doxorubicin—muscle cancer	0.000248	0.00126	CcSEcCtD
